Trial · NCT07902804
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adverse Event (part 1) | up to 2 years | |
| Primary | ORR (part 2) | up to 2 years | |
| Primary | Serious Adverse Event | up to 2 years | |
| Primary | Maximum Tolerated Dose (part 1) | up to 2 years | |
| Primary | DLT(Dose-limiting Toxicity) (part 1) | up to 2 years | |
| Secondary | PK concentration：IBI3043 serum concentration | up to 2 years | |
| Secondary | ADA (Anti-drug antibody) | up to 2 years | |
| Secondary | Nab (Neutralizing antibody) | up to 2 years | |
| Secondary | ORR (Objective Response Rate) (part 1) | up to 2 years | |
| Secondary | DoR (Duration of Response) | up to 2 years | |
| Secondary | TTR (Time to Response) | up to 2 years | |
| Secondary | PFS (Progression-free Survival) | up to 2 years | |
| Secondary | OS (Overall Survival) | up to 2 years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07902804/registered